Hayleigh Collins | executive |
Sean Nolan | executive |
Sukumar Nagendran | executive |
Kamran Alam | executive |
Yanan Zhu | analyst |
Jack Allen | analyst |
Kristen Kluska | analyst |
Silvan Tuerkcan | analyst |
Joon Lee | analyst |
Gil Blum | analyst |
Good morning. Welcome to Taysha Gene Therapies Second Quarter 2023 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this webcast is being recorded today, August 14, 2020.
I will now turn the call over to Hayleigh Collins, Director, Head of Corporate Communications. Please go ahead.